PolyPid Ltd. (NASDAQ:PYPD) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the PolyPid First Quarter 2023 Conference Call. At this time participants are in a listen-only mode. As a reminder this call is recorded.
Stay updated with breaking news from Advance Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Greetings, and welcome to the PolyPid First Quarter 2023 Conference Call. At this time participants are in a listen-only mode. As a reminder this call is recorded.
In a year dominated by the rhetoric of defending democracy, EU democracy support policies were adjusted in important ways to align with the new geopolitical context. However, the union also seemed to treat commitments in this area as second-order priorities compared to security.
A large Indian pharmaceutical delegation will visit Russia in July. It looks to explore business opportunities, including investment options to establish... 30.06.2022, Sputnik International
Advanz Pharma, which is backed by Nordic Capital, has agreed to acquire Intercept Pharmaceutical Inc.'s business in Europe, Canada and all other markets outside of the U.S.